Your Enquiry has not been submitted. Try again.
Thinoral® technology, our patent for manufacturing ODS is spread over 500 square meters, it is capable of manufacturing 324 million strips per annum. This dedicated facility for manufacturing ODS in various treatment areas has separate nutraceutical (products derived from food sources) and pharmaceutical manufacturing areas.
The technology has in exceptional cases been further advanced for the delivery of even liquid actives, also allowing successful incorporation of many taste masking techniques to facilitate easy delivery of bitter actives.
The technology is also suitable for the delivery of drugs through sublingual and buccal route, showing improved bioavailability by avoiding first pass metabolism. Even nanotechnology based formulations have been designed in this platform that retains all the desired product attributes.
Our EU-GMP compliance manufacturing facilities for fast disintegrating thin films manufacture various Pharmaceutical and Nutraceutical molecules such as, Rizatriptan, Methylcobalamin, Vitamin D3, Levocetirizine, Montelukast, Sildenafil, Tadalafil, Voglibose and so on.